Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canopy LATAM Corporation served as the regional headquarters for Canopy Growth Corporation's operations across Latin America. Headquartered in Bogota, Colombia, the company was established to manage the production, distribution, and research of medical cannabis products in markets including Colombia, Chile, Brazil, and Peru. The entity operated primarily through the Spectrum Therapeutics brand, focusing on providing standardized cannabinoid-based medicines to patients and healthcare providers. However, following a global strategic restructuring by its parent company that began in 2020, Canopy Growth transitioned to an asset-light model in the region. This shift led to the closure of its Colombian cultivation facilities and the eventual divestment of its Latin American business interests.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canopy LATAM Corporation.